Suppr超能文献

肉毒杆菌毒素注射会使食管肌层切开术的操作更困难吗?

Does botulinum toxin injection make esophagomyotomy a more difficult operation?

作者信息

Horgan S, Hudda K, Eubanks T, McAllister J, Pellegrini C A

机构信息

Department of Surgery, University of Washington, 1959 NE Pacific Street, Box 356410, Seattle, WA 98195, USA.

出版信息

Surg Endosc. 1999 Jun;13(6):576-9. doi: 10.1007/s004649901044.

Abstract

BACKGROUND

Some patients with achalasia treated by botulinum toxin injection still require an esophagomyotomy. In this study, we analyzed the impact of botulinum toxin injection on the technical aspects and outcome of esophagomyotomy.

METHODS

We studied 57 patients, with a mean age of 46 years (range, 12-97) who were treated between January 1995 and March 1998 by esophagomyotomy performed via minimally invasive techniques by one team. Operative reports, videotapes, and clinical outcome were analyzed to define the technical difficulties, perforations, and outcome.

RESULTS

Fifteen of the 57 patients had received one or more injections of botulinum toxin (botox group) preoperatively. Difficulties in dissection of the submucosal plane were encountered in eight of the 15 cases (53.3%), and a mucosal laceration (perforation) occurred in two cases (13.3%). Forty-two of the 57 patients had not received any injections (non-botox group). In three patients (7%), difficulties in identifying or following the submucosal plane were encountered, although 29 patients had one or more previous dilations, and perforation occurred in one case (2.4%). All mucosal injuries were repaired laparoscopically, and the patients recovered without obvious sequelae. Dysphagia improved significantly after the operation in both groups (botox group, from preoperative score of 3. 8 to a postoperative score of 0.7; non-botox, from a score of 3.4 preoperatively to 0.5 postoperatively). Regurgitation also improved in both groups (botox, 2.7 preoperatively, 0.92 postoperatively; non-botox group, 2.0 preoperatively, 0.56 postoperatively).

CONCLUSIONS

Injection of botulinum toxin significantly increases the technical difficulties and thus the potential risk of esophagomyotomy. The immediate results were equally good for both groups in our series, but the long-term sequelae of repeated injections are unknown. Laparoscopic Heller myotomy is a safe and effective procedure even after unsuccessful treatment with botulinum toxin.

摘要

背景

一些接受肉毒杆菌毒素注射治疗的贲门失弛缓症患者仍需要进行食管肌层切开术。在本研究中,我们分析了肉毒杆菌毒素注射对食管肌层切开术技术操作及手术结果的影响。

方法

我们研究了57例患者,平均年龄46岁(范围12 - 97岁),这些患者在1995年1月至1998年3月间由同一团队通过微创技术进行食管肌层切开术治疗。分析手术报告、录像带及临床结果,以明确技术难点、穿孔情况及手术结果。

结果

57例患者中有15例术前接受过一次或多次肉毒杆菌毒素注射(肉毒杆菌毒素组)。15例中有8例(53.3%)在黏膜下层分离时遇到困难,2例(13.3%)发生黏膜撕裂(穿孔)。57例患者中有42例未接受过任何注射(非肉毒杆菌毒素组)。尽管29例患者曾接受过一次或多次扩张治疗,但仍有3例(7%)在识别或追踪黏膜下层时遇到困难,1例(2.4%)发生穿孔。所有黏膜损伤均通过腹腔镜修复,患者恢复良好,无明显后遗症。两组患者术后吞咽困难均显著改善(肉毒杆菌毒素组,术前评分为3.8,术后为0.7;非肉毒杆菌毒素组,术前为3.4,术后为0.5)。两组反流情况也均有改善(肉毒杆菌毒素组,术前为2.7,术后为0.92;非肉毒杆菌毒素组,术前为2.0,术后为0.56)。

结论

肉毒杆菌毒素注射显著增加了食管肌层切开术的技术难度及潜在风险。在我们的系列研究中,两组的近期结果同样良好,但反复注射的长期后遗症尚不清楚。即使在肉毒杆菌毒素治疗失败后,腹腔镜Heller肌切开术仍是一种安全有效的手术。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验